$GWPH News Article - GW Pharmaceuticals Reports Positive Phase 3 Pivotal Trial Results for EPIDIOLEX (cannabidiol) Oral Solution in Patients with Seizures Associated With Tuberous Sclerosis Complex
https://marketwirenews.com/news-releases/gw-p...26068.html